Events for “moderna”

The Moderna cancer vaccine offers hope — now we must speed up personalized therapies

Nature, Published online: 28 August 2026; doi:10.1038/d41586-026-02680-5 A positive trial holds promise for treating people with cancer. More research is needed to get effective vaccines to the clinic.

Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math - WSJ

Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math WSJ Moderna, Merck breakthrough could usher in wave of cancer vaccines CNN Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope Reuters It now seems possible to vaccinate against c

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink - WSJ

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink WSJ Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math WSJ What it was like to go through a trial that could revolutionize cancer treatment The Washington Post Moderna, Merck breakthrough could usher

Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial

What’s in Merck and Moderna’s cancer vaccine algorithm?

A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout

Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial

BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?

Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?

STAT+: The mystery of Moderna’s magic algorithm

A personalized cancer vaccine developed by Moderna and Merck may be a triumph of immunology and cancer biology. It might also be the triumph of an algorithm.

STAT+: Inside Moderna and Merck’s cancer vaccine triumph

Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Nature, Published online: 20 August 2026; doi:10.1038/d41586-026-02612-3 Promising trial results suggest cancer vaccines work and could be used to target other tumours.

22 best-performing stocks of August, as the software industry continues its recovery

The energy and technology sectors did well in August, while Moderna’s stock was the best performer by a wide margin.

STAT+: Lady Gaga and her fiancé launch a biotech startup

FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more biotech news

STAT+: Are cancer patients getting too much drug?

Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout

A New Personalized Cancer Vaccine Could Keep Skin Cancer From Coming Back, Drugmakers Say

The results, announced this week by Moderna and Merck, could pave the way for a new generation of treatments tailored to individual tumors